Mar 14 |
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
|
Mar 5 |
First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference
|
Mar 4 |
First Wave Biopharma to raise about $4M of proceeds in direct offering
|
Mar 4 |
First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering
|
Feb 13 |
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
|
Jan 23 |
First Wave BioPharma to Present at the DealFlow MicroCap Conference
|
Jan 17 |
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
|
Jan 8 |
First Wave BioPharma files to sell 1.76M for holders
|
Jan 4 |
First Wave expecting "significant" investments if ImmunogenX deal closes
|
Jan 4 |
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|